In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “ammunition in the war against cancer.” Along with a picture of the Gleevec pills, ...
Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup Polymerase chain ...
First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study In a collaborative ...
ZURICH (Reuters) - Sun Pharma launched a generic version of Novartis's leukaemia drug Gleevec on Monday in the United States and hopes to poach a third of sales in six months by pricing the copycat ...
HealthDay News — The FDA has expanded indications for imatinib mesylate tablets (Gleevec, Novartis) to include treatment of adults who have undergone surgical removal of CD117-positive ...
Novartis will submit remibrutinib for approval in CSU to global health authorities starting in H2 2024. Scemblix demonstrated MMR rates at week 48 vs. investigator-selected SoC TKIs (67.7% vs. 49.0%) ...
BOGOTA (Reuters) - Colombia will set a new price for the Novartis cancer drug imatinib in a bid to cut healthcare costs after price negotiations with the Swiss company broke down, the health minister ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results